Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers

Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers

Triple-negative breast cancers (TNBCs) lack ER, PR and her2 receptors that are targets of common breast cancer therapies with poor prognosis due to their high rates of metastasis and chemoresistance. Based on our previous studies that epigenetic silencing of a potential metastasis suppressor, arrest...

Full description

Bibliographic Details
Main Authors: Young Hwa Soung, Heesung Chung, Cecilia Yan, Andrew Fesler, Hyungjin Kim, Eok-Soo Oh, Jingfang Ju, Jun Chung
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
ARRDC3
miR-489
CMM489
chemoresistance
triple-negative breast cancers
Online Access:https://www.mdpi.com/2072-6694/12/8/2209

Internet

https://www.mdpi.com/2072-6694/12/8/2209

Similar Items